Autologous Adipose Tissue Derived Insulin-Secreting Mesenchymal Stem Cell Transplantation In Late Onset of Autoimmune Mediated Diabetes Mellitus (LADA) Case Report

Authors

  • Shruti D Dave Junior scientific officer, Stem Cell Laboratory, Department of Pathology, Laboratory Medicine and Transfusion Services and Immunohematology. IKDRC-ITS, Ahmedabad.
  • Aruna V Vanikar Department of Pathology, Laboratory Medicine and Transfusion Services and Immunohematology, G. R. Doshi and K. M. Mehta Institute Of Kidney Diseases & Research Centre (IKDRC)- Dr. H.L. Trivedi Institute Of Transplantation Sciences (ITS), Civil Hospital Campus, Asarwa, Ahmedabad- 380016, Gujarat, India.
  • Hargovind L Trivedi Department of Nephrology and Transplantation Medicine
  • Umang G Thakkar Department of Nephrology and Transplantation Medicine

DOI:

https://doi.org/10.7439/ijbr.v4i3.230

Keywords:

Laparoscopy, Right Iliac Fossa pain, Appendicitis.

Abstract

Latent autoimmune diabetes of adults (LADA) is a term describing patients with a type 2 diabetic phenotype combined with islet antibodies and slowly progressive ?-cell failure. Insulin therapy is the treatment of choice. We report a 36-years-male with LADA since 4 years, treated with insulin-secreting human adipose tissue derived mesenchymal stem cells (IS-ADMSC). He was glutamic acid decarboxylase antibody positive (26 IU/ml). He was on insulin, 65 International units (IU) and 4 OHG/day. Autologous IS-ADMSC + bone marrow-derived haematopoietic stem cells (HSC) were infused into subcutaneous, portal and thymic circulation with conditioning of bortezomibe and rabbit-antithymoglobulin. Over follow-up of 18 months he is doing well with sustained fall of glycosylated haemoglobin from 12.7 to 6.7% and with sustained 60% decreased insulin requirement with sustained control of the plasma blood glucose level. Thus long-term control of LADA with co-transplantation of IS-ADMSC+HSC can be achieved safely and effectively.

Downloads

Download data is not yet available.

Author Biographies

  • Shruti D Dave, Junior scientific officer, Stem Cell Laboratory, Department of Pathology, Laboratory Medicine and Transfusion Services and Immunohematology. IKDRC-ITS, Ahmedabad.
    Junior scientific officer,Stem Cell Laboratory, Department of Pathology, Laboratory Medicine and Transfusion Services and Immunohematology.
  • Hargovind L Trivedi, Department of Nephrology and Transplantation Medicine
    Director to IKDRC-ITS,Department of Nephrology and Transplantation Medicine,G. R. Doshi and K. M. Mehta Institute Of Kidney Diseases & Research Centre (IKDRC)- Dr. H.L. Trivedi Institute Of Transplantation Sciences (ITS), Civil Hospital Campus, Asarwa, Ahmedabad- 380016, Gujarat, India.
  • Umang G Thakkar, Department of Nephrology and Transplantation Medicine
    Department of Nephrology and Transplantation Medicine,G. R. Doshi and K. M. Mehta Institute Of Kidney Diseases & Research Centre (IKDRC)- Dr. H.L. Trivedi Institute Of Transplantation Sciences (ITS), Civil Hospital Campus, Asarwa, Ahmedabad- 380016, Gujarat, India.

Downloads

Published

2013-04-01

Issue

Section

Case Report

How to Cite

1.
Autologous Adipose Tissue Derived Insulin-Secreting Mesenchymal Stem Cell Transplantation In Late Onset of Autoimmune Mediated Diabetes Mellitus (LADA) Case Report. Int Jour of Biomed Res [Internet]. 2013 Apr. 1 [cited 2024 Oct. 18];4(3):153-6. Available from: https://ssjournals.co.in/index.php/ijbr/article/view/816

Similar Articles

1-10 of 22

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

<< < 118 119 120 121 122 123 124 125 126 127 > >>